Skip to main content

DMK Pharmaceuticals Corp

DMKDelisted Mar 21, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000887247

DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in DMK Pharmaceuticals Corp as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
−3 vs. Q4 2021
Shares held
12.9M
−1.26M (−8.9%) vs. Q4 2021
Total value
$7.38M
−$1.20M (−14.0%) vs. Q4 2021
New holders
4
7 more added
Sold out
7
13 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 46 institutions
Q1 2021: 53 institutionsQ2 2021: 51 institutionsQ3 2021: 53 institutionsQ4 2021: 49 institutionsQ1 2022: 46 institutionsQ2 2022: 45 institutionsQ3 2022: 43 institutionsQ4 2022: 48 institutionsQ1 2023: 47 institutionsQ2 2023: 22 institutionsQ3 2023: 25 institutionsQ4 2023: 29 institutionsQ1 2024: 3 institutionsQ2 2024: 2 institutionsQ3 2024: 2 institutionsQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 2 institutionsQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2022: $7.38M
Q1 2021: $11.8MQ2 2021: $17.8MQ3 2021: $14.6MQ4 2021: $8.58MQ1 2022: $7.38MQ2 2022: $6.44MQ3 2022: $2.55MQ4 2022: $2.16MQ1 2023: $3.20MQ2 2023: $276.4KQ3 2023: $178.7KQ4 2023: $350.4KQ1 2024: $4Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding DMK and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20252$0
Q3 20251$0
Q2 20251$0
Q1 20251$0
Q4 20241$0
Q3 20242$0
Q2 20242$0
Q1 20243$4
Q4 202329$350.4K
Q3 202325$178.7K
Q2 202322$276.4K
Q1 202347$3.20M
Q4 202248$2.16M
Q3 202243$2.55M
Q2 202245$6.44M
Q1 202246$7.38M
Q4 202149$8.58M
Q3 202153$14.6M
Q2 202151$17.8M
Q1 202153$11.8M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding DMK Pharmaceuticals Corp; share changes are against Q4 2021.

Institutions holding DMK in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc6,480,688$3.70M0.00%−38,168−0.6%Reduced
BlackRock Inc.2,781,966$1.59M0.00%+27,147+1.0%Added
Geode Capital Management, LLC1,293,316$738.0K0.00%00.0%Unchanged
State Street Corp475,373$271.0K0.00%+55,168+13.1%Added
Northern Trust Corp258,851$148.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP173,979$99.0K0.00%−304,382−63.6%Reduced
Tower Research Capital LLC (TRC)167,000$95.0K0.00%+112,868+208.5%Added
Morgan Stanley110,228$63.0K0.00%−26,935−19.6%Reduced
Edmond de Rothschild Holding S.A.100,000$57.0K0.00%00.0%Unchanged
Creative Planning85,000$49.0K0.00%+63,000+286.4%Added
JPMorgan Chase & Co84,775$48.0K0.00%−133,798−61.2%Reduced
Bank of New York Mellon Corp84,002$48.0K0.00%00.0%Unchanged
Capital CS Group, LLC70,513$40.0K0.03%+70,513New
UBS Group AG66,653$39.0K0.00%−78,691−54.1%Reduced
Cambridge Investment Research Advisors, Inc.64,349$37.0K0.00%−500−0.8%Reduced
Verdence Capital Advisors LLC58,382$33.0K0.00%−85,000−59.3%Reduced
Charles Schwab Investment Management Inc56,257$33.0K0.00%00.0%Unchanged
Citadel Advisors LLC48,048$27.0K0.00%−372,803−88.6%Reduced
HighTower Advisors, LLC49,350$27.0K0.00%+10,000+25.4%Added
Lido Advisors, LLC46,721$26.0K0.00%00.0%Unchanged
Bank of America Corp41,092$24.0K0.00%+6,536+18.9%Added
Regions Financial Corp34,500$20.0K0.00%00.0%Unchanged
National Asset Management, Inc.25,210$15.0K0.00%00.0%Unchanged
Avantax Advisory Services, Inc.22,000$13.0K0.00%−32,000−59.3%Reduced
Global Strategic Investment Solutions, LLC23,000$13.0K0.00%00.0%Unchanged
Stonebridge Capital Advisors LLC22,000$13.0K0.00%00.0%Unchanged
Founders Capital Management18,000$11.0K0.01%00.0%Unchanged
RVW Wealth, LLC19,000$11.0K0.00%00.0%Unchanged
Principal Financial Group Inc16,872$10.0K0.00%−950−5.3%Reduced
Atria Wealth Solutions, Inc.15,000$9.00K0.00%+15,000New
Victory Capital Management Inc20,426$8.00K0.00%−583−2.8%Reduced
Affinity Capital Advisors, LLC13,180$8.00K0.00%00.0%Unchanged
Goldman Sachs Group Inc12,615$7.00K0.00%−7,021−35.8%Reduced
Squarepoint Ops LLC11,729$7.00K0.00%−1,927−14.1%Reduced
Advisor Group Holdings, Inc.12,691$7.00K0.00%00.0%Unchanged
Oppenheimer & Co Inc12,000$7.00K0.00%00.0%Unchanged
Cetera Investment Advisers10,200$6.00K0.00%00.0%Unchanged
We Are One Seven, LLC10,615$6.00K0.00%00.0%Unchanged
Wolff Wiese Magana LLC10,740$6.00K0.00%00.0%Unchanged
Coastal Capital Group, Inc.5,100$3.00K0.00%00.0%Unchanged
Royal Bank of Canada5,000$3.00K0.00%+5,000New
Allworth Financial LP3,530$2.00K0.00%00.0%Unchanged
Wells Fargo & Company916$1.00K0.00%+3+0.3%Added
Signaturefd, LLC863$00.00%00.0%Unchanged
Winch Advisory Services, LLC73$00.00%00.0%Unchanged
Citigroup Inc250$00.00%+250New
Virtu Financial LLC0$00.00%−224,561−100.0%Sold out
Millennium Management LLC0$00.00%−138,666−100.0%Sold out
Atom Investors LP0$00.00%−75,209−100.0%Sold out
Jane Street Group, LLC0$00.00%−41,716−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−22,906−100.0%Sold out
HRT Financial LP0$00.00%−21,321−100.0%Sold out
Wolverine Trading, LLC0$00.00%−14,643−100.0%Sold out